Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Verona Pharma Plc ADR (VRNA)

Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,149,281
  • Shares Outstanding, K 79,480
  • Annual Sales, $ 0 K
  • Annual Income, $ -54,370 K
  • 60-Month Beta 0.34
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.55
Trade VRNA with:

Options Overview Details

View History
  • Implied Volatility 67.23% ( -9.73%)
  • Historical Volatility 70.98%
  • IV Percentile 40%
  • IV Rank 22.95%
  • IV High 224.47% on 06/10/24
  • IV Low 20.40% on 01/26/24
  • Put/Call Vol Ratio 1.05
  • Today's Volume 5,128
  • Volume Avg (30-Day) 2,942
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 30,396
  • Open Int (30-Day) 13,894

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.35
  • Number of Estimates 4
  • High Estimate -0.32
  • Low Estimate -0.40
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -218.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.39 +26.95%
on 05/30/24
17.00 -14.94%
on 06/17/24
+2.03 (+16.33%)
since 05/28/24
3-Month
11.39 +26.95%
on 05/30/24
17.25 -16.17%
on 04/05/24
-1.63 (-10.13%)
since 03/28/24
52-Week
11.39 +26.95%
on 05/30/24
23.07 -37.32%
on 07/17/23
-6.30 (-30.35%)
since 06/28/23

Most Recent Stories

More News
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022

The healthcare sector is no slouch when it comes to top-performing growth stocks.

NVDA : 123.54 (-0.36%)
TMDX : 150.62 (+1.89%)
LLY : 905.38 (-0.40%)
VRNA : 14.46 (-6.35%)
3 Stocks That Could Be Monster Winners in 2024

Don't be surprised if these three stocks take off in the new year.

CRSP : 54.01 (-2.47%)
MDGL : 280.16 (-1.93%)
VRNA : 14.46 (-6.35%)
Lucid Is Revving Up, but This Nasdaq Stock Is Jumping Even More

Investors hoped for a rebound in the stock market, but they might have to settle for gains in these two stocks.

COMP : 3.60 (-2.44%)
$NASX : 17,732.60 (-0.71%)
LCID : 2.61 (-2.25%)
VRNA : 14.46 (-6.35%)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers

Small-cap biotech Catalyst Pharmaceuticals has been outperforming the broader market amid earnings and revenue acceleration. It joined the S&P 600 last month.

SPSM : 41.53 (+0.97%)
CPRX : 15.49 (+2.99%)
CG : 40.15 (+0.65%)
APLS : 38.36 (-7.61%)
AERI : 15.25 (+0.07%)
BLTE : 45.68 (-1.76%)
VRNA : 14.46 (-6.35%)
RVNC : 2.57 (-0.39%)
Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering

LONDON and RALEIGH, N.C., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage...

VRNA : 14.46 (-6.35%)
Verona Pharma plc Announces Proposed Underwritten Public Offering

LONDON and RALEIGH, N.C., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage...

VRNA : 14.46 (-6.35%)
Why Verona Pharma Stock Is Skyrocketing Today

The company reported overwhelmingly positive results from a late-stage study of its COPD drug candidate.

VRNA : 14.46 (-6.35%)
Verona Pharma (NASDAQ: VRNA) Reports its Phase 3 ENHANCE-2 Trial of Ensifentrine Met Primary Endpoint in Treating COPD

Verona Pharma plc (NASDAQ: VRNA) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, development and

VRNA : 14.46 (-6.35%)
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Ensifentrine met primary and secondary endpoints of evaluating lung function in Phase 3 ENHANCE-2 trial for COPD Top-line Phase 3 ENHANCE-1 data...

VRNA : 14.46 (-6.35%)
Verona Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-2 Trial for COPD

Statistically significant improvements in key measures of lung function 42% reduction in rate of exacerbations over 24 weeks Well tolerated with safety...

VRNA : 14.46 (-6.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Verona Pharma plc is a clinical-stage biopharmaceutical company. It researches, discovers and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. Verona Pharma plc is based in London, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 16.35
2nd Resistance Point 15.85
1st Resistance Point 15.15
Last Price 14.46
1st Support Level 13.95
2nd Support Level 13.45
3rd Support Level 12.75

See More

52-Week High 23.07
Fibonacci 61.8% 18.61
Fibonacci 50% 17.23
Fibonacci 38.2% 15.85
Last Price 14.46
52-Week Low 11.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar